BlackRock’s Soleno Therapeutics SLNO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$238M Buy
2,844,747
+931,421
+49% +$78M ﹤0.01% 1510
2025
Q1
$137M Sell
1,913,326
-96,464
-5% -$6.89M ﹤0.01% 1797
2024
Q4
$90.3M Sell
2,009,790
-2,027
-0.1% -$91.1K ﹤0.01% 2114
2024
Q3
$102M Buy
2,011,817
+148,363
+8% +$7.49M ﹤0.01% 2058
2024
Q2
$76M Buy
1,863,454
+1,537,156
+471% +$62.7M ﹤0.01% 2173
2024
Q1
$14M Buy
326,298
+12,637
+4% +$541K ﹤0.01% 3124
2023
Q4
$12.6M Buy
313,661
+313,408
+123,877% +$12.6M ﹤0.01% 3204
2023
Q3
$7.47K Sell
253
-89
-26% -$2.63K ﹤0.01% 5151
2023
Q2
$1.47K Hold
342
﹤0.01% 5297
2023
Q1
$731 Hold
342
﹤0.01% 5392
2022
Q4
$677 Hold
342
﹤0.01% 5571
2022
Q3
$0 Sell
342
-2
-0.6% ﹤0.01% 5800
2022
Q2
$1K Sell
344
-8,344
-96% -$24.3K ﹤0.01% 5718
2022
Q1
$29K Sell
8,688
-401
-4% -$1.34K ﹤0.01% 5426
2021
Q4
$56K Buy
9,089
+437
+5% +$2.69K ﹤0.01% 5311
2021
Q3
$120K Buy
8,652
+7,759
+869% +$108K ﹤0.01% 5031
2021
Q2
$16K Sell
893
-198,086
-100% -$3.55M ﹤0.01% 5239
2021
Q1
$3.76M Buy
198,979
+3,423
+2% +$64.7K ﹤0.01% 4010
2020
Q4
$5.66M Buy
195,556
+15,868
+9% +$459K ﹤0.01% 3577
2020
Q3
$6.77M Buy
179,688
+76,676
+74% +$2.89M ﹤0.01% 3350
2020
Q2
$3.43M Buy
103,012
+97,296
+1,702% +$3.24M ﹤0.01% 3590
2020
Q1
$205K Buy
5,716
+1,152
+25% +$41.3K ﹤0.01% 4150
2019
Q4
$201K Sell
4,564
-37
-0.8% -$1.63K ﹤0.01% 4255
2019
Q3
$103K Sell
4,601
-203
-4% -$4.54K ﹤0.01% 4386
2019
Q2
$202K Buy
4,804
+2,221
+86% +$93.4K ﹤0.01% 4310
2019
Q1
$80K Sell
2,583
-104
-4% -$3.22K ﹤0.01% 4358
2018
Q4
$69K Sell
2,687
-32
-1% -$822 ﹤0.01% 4376
2018
Q3
$88K Buy
2,719
+68
+3% +$2.2K ﹤0.01% 4406
2018
Q2
$93K Buy
2,651
+1,611
+155% +$56.5K ﹤0.01% 4415
2018
Q1
$28K Hold
1,040
﹤0.01% 4474
2017
Q4
$28K Hold
1,040
﹤0.01% 4455
2017
Q3
$41K Buy
1,040
+5
+0.5% +$197 ﹤0.01% 4441
2017
Q2
$39K Buy
1,035
+7
+0.7% +$264 ﹤0.01% 4486
2017
Q1
$54K Buy
+1,028
New +$54K ﹤0.01% 4396